Table:
begin	end	state
1	6	cytoplasmic
7	31	transmembrane
32	54	non-cytoplasmic
55	89	transmembrane
90	100	cytoplasmic
101	124	transmembrane
125	146	non-cytoplasmic
147	177	transmembrane
178	188	cytoplasmic
189	216	transmembrane
217	224	non-cytoplasmic
225	245	transmembrane
246	270	cytoplasmic
271	291	transmembrane
292	296	non-cytoplasmic
297	314	transmembrane
315	333	cytoplasmic
334	352	transmembrane
353	362	non-cytoplasmic
363	384	transmembrane
385	389	cytoplasmic
390	410	transmembrane
411	424	non-cytoplasmic
425	450	transmembrane
451	469	cytoplasmic
470	493	transmembrane
494	499	non-cytoplasmic

Input:
>GFF3083
MAGKLGTWLMIIATVGLAFVICVELINILFYDPWSDEKFLFKLSGSLSGVEIGPLTYLMF
GSLAVALMMGLPLAFVTGGLGVMFIYLVGDAMMLNIVPGRIFPLMANPDIAAIPLFIFMA
SMLERAGLIEEMFSVVYKWMGGISGGLAAATIVASTILAAMVGVIGAAVVTMGIIALPAM
LKRHYDHKIAIGSIMAGGTLGILIPPSILAILYAVVAQQSVGELYLGSLLPGLMLSGLYL
TYVLVRSWLNPKLGPPIPVEDRISLKEKLKLLGNLIAPLALVGLVLGLLFGGIATPVEAA
GIGSFGAIIVAMMHKKFSIAGLREASVTTAKASAMVLWIMFGASVFVGFYILQGGQQFVT
DAILGTGMSAYGILFLLMVLLVVLGMFLDWVGILLLAVPIFIPIVKALEFPGLFGFPPVA
GDDVVLWFGVLYLVNMQMSFLSPPFGYALFYIRGVCPPEISMGTIFKSSLVFLAIQAFGL
FMCVLIPGIVTWLPGLVYG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server